Bulletin
Investor Alert

New York Markets Close in:

Medexus Pharmaceuticals Inc.

TSE: CA:MDP

GO

Quotes are delayed by 15 min

Feb 1, 2023, 11:00 a.m.

MDP
/zigman2/quotes/208555543/delayed

$

1.86

Change

-0.04 -2.11%

Volume

Volume 3,756

Quotes are delayed by 15 min

/zigman2/quotes/208555543/delayed

Previous close

$ 1.90

$ 1.86

Change

-0.04 -2.11%

Day low

Day high

$1.84

$1.89

Open

52 week low

52 week high

$0.88

$3.45

Open

Richard Labelle

Currently, Richard Labelle is Vice President-Marketing & Sales at Medexus Pharmaceuticals, Inc. Mr. Labelle is also on the board of Cobra International Systemes de Fixations Cie Ltee.

In the past Mr. Labelle was Vice President & General Manager at Sanofi-Aventis Healthcare Pty Ltd.

Richard Labelle received an undergraduate degree from Université du Québec à Montréal and an MBA from Mcgill Hec Montreal.

Transactions

Date Shares Transaction Value
06/21/2021 3,260   23,472
06/21/2021 3,260   23,472
12/19/2018 193,162   0
12/19/2018 193,162   0

Officers and Executives

Mr. Kenneth d’Entremont
Chief Executive Officer & Director
Mr. Richard Labelle
VP-Allergy, Pediatric & OTC Portfolios
Mr. Marcel Konrad
Chief Financial Officer
Mr. Ian C. Wildgoose Brown
Secretary & General Counsel
Mr. Peter A. van der Velden
Chairman
Ms. Adele M. Gulfo
Independent Director
Mr. Michael Peter Mueller
Independent Director
Mr. Benoit Gravel
Independent Director
Mr. Stephen Nelson
Independent Director
Link to MarketWatch's Slice.